Editorial: Immune Cell Lineage Reprogramming in Cancer

• Jianmei W. Leavenworth,
• Jianmei W. Leavenworth,
• Jianmei W. Leavenworth,
• Lewis Zhichang Shi,
• Lewis Zhichang Shi,
• Lewis Zhichang Shi,
• Xi Wang,
• Xi Wang,
• Xi Wang,
• Xi Wang,
• Haiming Wei,
• Haiming Wei

Affiliations

Jianmei W. Leavenworth

Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, United States

Jianmei W. Leavenworth

The O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States

Jianmei W. Leavenworth

Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United States

Lewis Zhichang Shi

The O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States

Lewis Zhichang Shi

Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United States

Lewis Zhichang Shi

Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States

Xi Wang

Institute of Infectious Diseases, Beijing Key Laboratory of Emerging Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China

Xi Wang

Beijing Institute of Infectious Diseases, Beijing, China

Xi Wang

National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China

Xi Wang

Department of Oncology, Capital Medical University, Beijing, China

Haiming Wei

Hefei National Laboratory for Physical Sciences at Microscale, Division of Life Science and Medicine, University of Science and Technology of China, Heifei, China

Haiming Wei

0Institute of Immunology, University of Science and Technology of China, Heifei, China